2,217
Views
11
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Effect and mechanism of paclitaxel loaded on magnetic Fe3O4@mSiO2-NH2-FA nanocomposites to MCF-7 cells

, , , , , , , & show all
Pages 64-82 | Received 14 Oct 2022, Accepted 28 Nov 2022, Published online: 06 Dec 2022

References

  • Abdallah QM, Kazi M, Khaleel MA, et al. (2020). Utilization of novel self-nanoemulsifying formulations (SNEFs) loaded paclitaxel for the treatment prosperity of bladder cancer. J Drug Deliv Sci Tec 56:101514.
  • Alavi M, Nokhodchi A. (2022). Micro- and nanoformulations of paclitaxel based on micelles, liposomes, cubosomes, and lipid nanoparticles: recent advances and challenges. Drug Discov Today 27:576–84.
  • Al-Hilfi A, Walker KD. (2022). Biocatalysis of precursors to new-generation SB-T-taxanes effective against paclitaxel-resistant cancer cells. Arch Biochem Biophys 719:109165.
  • Araya-Sibaja AM, Wilhelm-Romero K, Quiros-Fallas MI, et al. (2022). Bovine serum albumin-based nanoparticles: preparation, characterization, and antioxidant activity enhancement of three main curcuminoids from Curcuma longa. Molecules 27:2758.
  • Arumugam B, Nagarajan V, Perumal KN, et al. (2022). Fabrication of wurtzite ZnO embedded functionalized carbon black as sustainable electrocatalyst for detecting endocrine disruptor trichlorophenol. Microchem J 175:107202.
  • Caldera F, Nistico R, Magnacca G, et al. (2022). Magnetic composites of dextrin-based carbonate nanosponges and iron oxide nanoparticles with potential application in targeted drug delivery. Nanomaterials 12:754.
  • Calzaferri G, Gallagher SH, Brühwiler D. (2021). Argon and nitrogen adsorption isotherms of nonporous, microporous, and mesoporous materials. Microporous Mesoporous Mater 312:110744.
  • Chen S, Liu Q, He XY, et al. (2022a). One-step synthesis of nanoscale anhydrous calcium sulfate whiskers: direct conversion of calcium carbonate by mixed acid with microemulsion method. J Nanopart Res 24:4.
  • Chen X, Wang M, Hu Y, et al. (2020). Low-dose paclitaxel via hyaluronan functionalized bovine serum albumin nanoparticulate assembly for metastatic melanoma treatment. J Mater Chem B 8:2139–47.
  • Chen XL, Ji JB, Zhou K, et al. (2022b). A novel multifunctional nanoparticles formed by molecular recognition between AS1411 aptamer and redox-responsive paclitaxel-nucleoside analogue prodrug for combination treatment of β-lapachone and paclitaxel. Colloids Surf B Biointerfaces 212:112345.
  • Cheng L, Yang J, Tseng CC, et al. (2022). Outdoor ambient air pollution and breast cancer survival among California participants of the Multiethnic Cohort Study. Environ Int 161:102088.
  • Deng YQ, Li J, Sun CY, et al. (2022). Rational development of a polysaccharide-protein-conjugated nanoparticle vaccine against SARS-CoV-2 variants and Streptococcus pneumoniae. Adv Mater 34:2200443.
  • Dinparvar S, Bagirova M, Allahverdiyev AM, et al. (2020). A nanotechnology-based new approach in the treatment of breast cancer: biosynthesized silver nanoparticles using Cuminum cyminum L. seed extract. J Photochem Photobiol B 208:111902.
  • Dong SY, Bi Y, Sun XS, et al. (2022). Dual-loaded liposomes tagged with hyaluronic acid have synergistic effects in triple-negative breast cancer. Small 18:2107690.
  • Duan HX, Liu C, Hou Y, et al. (2022). Sequential delivery of quercetin and paclitaxel for the fibrotic tumor microenvironment remodeling and chemotherapy potentiation via a dual-targeting hybrid micelle-in-liposome system. ACS Appl Mater Interfaces 14:10102–16.
  • Dutta B, Shelar SB, Rajan V, et al. (2022). Gelatin grafted Fe3O4 based curcumin nanoformulation for cancer therapy. J Drug Deliv Sci Tec 67:102974.
  • Efetov SK, Zubayraeva AA, Nekoval VM, et al. (2020). Extended colectomy followed by cecorectal anastomosis as a surgical treatment modality in synchronous colorectal cancer. Case Rep Oncol 13:813–21.
  • Fang ZZ, Li XY, Xu ZY, et al. (2019). Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe3O4 nanoparticles for targeted drug delivery. Int J Nanomedicine 14:5785–97.
  • Fu Y, Yang SY, Liu YN, et al. (2022). Peptide modified albumin-paclitaxel nanoparticles for improving chemotherapy and preventing metastasis. Macromol Biosci 22:2100404.
  • Fukushima K, Lee SY, Tanaka K, et al. (2022). Effect of surface modification for carbon cathode materials on charge-discharge performance of li-air batteries. Materials 15:3270.
  • Gade JV, Sharma PP, Jain B, et al. (2022). Synthesis and characterization of paclitaxel nanoparticles for drug delivery. Mater Today: Proc 51:445–50.
  • Gan YH, Zhang J, Lei SL, et al. (2022). Atomically precise multi-domain GdxFe3-xO4 nanoclusters with modulated contrast properties for T2-weighted magnetic resonance imaging of early orthotopic cancer. Chem Eng J 429:132255.
  • Gong HX, Li WA, Sun JL, et al. (2022). A review on plant polysaccharide based on drug delivery system for construction and application, with emphasis on traditional Chinese medicine polysaccharide. Int J Biol Macromol 211:711–28.
  • Guari Y, Cahu M, Félix G, et al. (2022). Nanoheterostructures based on nanosized Prussian blue and its analogues: design, properties and applications. Coordin Chem Rev 461:214479.
  • Guay E, Cordeiro E, Roberts A. (2022). ASO visual abstract: young women with breast cancer: chemotherapy or surgery first? An evaluation of time to treatment for invasive breast cancer. Ann Surg Oncol 29:2262. 
  • Gulsu A, Killi B, Alper M. (2022). Paclitaxel delivery by cationic gelatin nanoparticles. Chemistryselect 7:e202103495.
  • Hashida N, Shamoto H, Maeda K, et al. (2021). Impact of geniohyoid and masseter muscle masses on dysphagia after salvage surgery and radiotherapy in head and neck cancer. Sci Rep 11:2278.
  • Hata S, Shin T, Abe S, et al. (2021). Degarelix as a neoadjuvant hormonal therapy for acute urinary tract toxicity associated with external beam radiotherapy for intermediate- and high-risk prostate cancer: a propensity score matched analysis. Jpn J Clin Oncol 51:478–483.
  • He CY, Majd MH, Shiri F, et al. (2021). Palladium and platinum complexes of folic acid as new drug delivery systems for treatment of breast cancer cells. J Mol Struct 1229:129806.
  • Işıklan N, Hussien NA, Türk M. (2022). Multifunctional aptamer-conjugated magnetite graphene oxide/chlorin e6 nanocomposite for combined chemo-phototherapy. Colloids Surface A 645:128841.
  • Jarvis CA, Bonney PA, Ding L, et al. (2020). Readmission with venous thromboembolism after surgical treatment by primary cancer site. Surg Oncol 35:268–275.
  • Jiang HF, Chen WJ, Wang J, et al. (2022). Selective N-terminal modification of peptides and proteins: recent progresses and applications. Chinese Chem Lett 33:80–88.
  • Kalia S, Rana DS, Thakur N, et al. (2022). Two-dimensional layered molybdenum disulfide (MoS2)-reduced graphene oxide (rGO) heterostructures modified with Fe3O4 for electrochemical sensing of epinephrine. Mater Chem Phys 287:126274.
  • Karampinis L, Dionysopoulou A, Galata C, et al. (2022). Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: a systematic literature review and pooled analysis. Thorac Cancer 13:883–888.
  • Ketelut-Carneiro N, Fitzgerald KA. (2022). Apoptosis, pyroptosis, and necroptosis—oh my! The many ways a cell can die. J Mol Biol 434:167378.
  • Killelea BK, Jeph H, Soulos PR, et al. (2020). Income disparities in needle biopsy patients prior to breast cancer surgery across physician peer groups. Breast Cancer 27:381–388.
  • Kong N, Chen X, Feng J, et al. (2021). Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1. Acta Pharm Sin B 11:4045–4054.
  • Kovrigina E, Chubarov A, Dmitrienko E. (2022). High drug capacity doxorubicin-loaded iron oxide nanocomposites for cancer therapy. Magnetochemistry 8:54.
  • Kuang WW, Hu WL, Ren H, et al. (2021). Plant derived coumestrol phytochemical targets human skin carcinoma cells by inducing mitochondrial-mediated apoptosis, cell cycle arrest, inhibition of cell migration and invasion and modulation of m-TOR/PI3K/AKT signalling pathway. Saudi J Biol Sci 28:2739–2746.
  • Kumar R, Singh RK, Alaferdov AV, et al. (2018). Rapid and controllable synthesis of Fe3O4 octahedral nanocrystals embedded-reduced graphene oxide using microwave irradiation for high performance lithium-ion batteries. Electrochim Acta 281:78–87.
  • Kumar R, Youssry SM, Ya KZ, et al. (2020). Microwave-assisted synthesis of Mn3O4-Fe2O3/Fe3O4@rGO ternary hybrids and electrochemical performance for supercapacitor electrode. Diam Relat Mater 101:107622.
  • Kumar S, Clair DS. (2021). Radioresistance in prostate cancer: focus on the interplay between NF-κB and SOD. Antioxidants 10:1925.
  • Kumari M, Kamat S, Jayabaskaran C. (2022). Usnic acid induced changes in biomolecules and their association with apoptosis in squamous carcinoma (A-431) cells: a flow cytometry, FTIR and DLS spectroscopic study. Spectrochim Acta A 274:121098.
  • Lee J, Ham JY, Park HY, et al. (2022). Feasibility of targeted cascade genetic testing in the family members of BRCA1/2 gene pathogenic variant/likely pathogenic variant carriers. Sci Rep 12:1842.
  • Li B, Tan TF, Chu WW, et al. (2022a). Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy. Drug Deliv 29:75–88.
  • Li S, Huan YF, Zhu B, et al. (2022b). Research progress on the biological modifications of implant materials in 3D printed intervertebral fusion cages. J Mater Sci-Mater M 33:2.
  • Li XQ, Ma FH, Yang MH, et al. (2022c). Nanomaterial based analytical methods for breast cancer biomarker detection. Mater Today Adv 14:100219.
  • Li YH, Wang XF, Zou SJ, et al. (2022d). Nanocomposites of immobilized nano-zirconia on low-cost activated carbon derived from hazelnut shell for enhanced removal of 3-nitro-4-hydroxy-phenylarsonic acid from water. Environ Res 209:112851.
  • Liu RJ, Rong GX, Liu YH, et al. (2021). Delivery of apigenin-loaded magnetic Fe2O3/Fe3O4@mSiO2 nanocomposites to A549 cells and their antitumor mechanism. Mater Sci Eng C Mater Biol Appl 120:111719.
  • Liu RJ, Zhang YL, Deng P, et al. (2022). Construction of targeted delivery system for curcumin loaded on magnetic α-Fe2O3/Fe3O4 heterogeneous nanotubes and its apoptosis mechanism on MCF-7 cell. Biomater Adv 136:212783.
  • Liu TI, Lu TY, Yang YC, et al. (2020). New combination treatment from ROS-induced sensitized radiotherapy with nanophototherapeutics to fully eradicate orthotopic breast cancer and inhibit metastasis. Biomaterials 257:120229.
  • Michałowska A, Kudelski A. (2022). The first silver-based plasmonic nanomaterial for shell-isolated nanoparticle-enhanced raman spectroscopy with magnetic properties. Molecules 27:3081.
  • Mubarik S, Sharma R, Hussain SR. (2022). Breast cancer mortality trends and predictions to 2030 and its attributable risk factors in East and South Asian Countries. Front Nutr 9:847920.
  • Ni Y, Lv ZX, Wang Z, et al. (2022). Immobilization and evaluation of penicillin G acylase on hydroxy and aldehyde functionalized magnetic α-Fe2O3/Fe3O4 heterostructure nanosheets. Front Bioeng Biotech 9:812403.
  • Obayemi JD, Jusu SM, Salifu AA, et al. (2020). Degradable porous drug-loaded polymer scaffolds for localized cancer drug delivery and breast cell/tissue growth. Mater Sci Eng C Mater Biol Appl 112:110794.
  • Patel A, Kosmacek EA, Fisher KW, et al. (2020). MnTnBuOE-2-PyP treatment protects from radioactive iodine (I-131) treatment-related side effects in thyroid cancer. Radiat Environ Biophys 59:99–109.
  • Resen AK, Atiroğlu A, Atiroğlu V, et al. (2022). Effectiveness of 5-Fluorouracil and gemcitabine hydrochloride loaded iron-based chitosan-coated MIL-100 composite as an advanced, biocompatible, pH-sensitive and smart drug delivery system on breast cancer therapy. Int J Biol Macromol 198:175–186.
  • Ro E, Vu V, Wei YD. (2022). Ambient air emissions of endocrine-disrupting metals and the incidence of hormone receptor- and HER2-dependent female breast cancer in USA. Med Oncol 39:69.
  • Sakhi M, Khan A, Iqbal Z, et al. (2022). Design and characterization of paclitaxel-loaded polymeric nanoparticles decorated with trastuzumab for the effective treatment of breast cancer. Front Pharmacol 13:855294.
  • Santos JG, Lopes H, Moreno H, et al. (2021). Towards anti-angiogenic activity of NiFe2O4 nanoparticles. Ceram Int 47:16152–16161.
  • Shahdeo D, Roberts A, Kesarwani V, et al. (2022). Polymeric biocompatible iron oxide nanoparticles labeled with peptides for imaging in ovarian cancer. Bioscience Rep 42:BSR20212622.
  • Shams A, Shabani R, Asgari H, et al. (2022). In vitro elimination of EL4 cancer cells from spermatogonia stem cells by miRNA-143-and 206-loaded folic acid conjugated PLGA nanoparticles. Nanomedicine (Lond) 17:531–545.
  • Singh A, Amiji MM. (2022). Application of nanotechnology in medical diagnosis and imaging. Curr Opin Biotechnol 74:241–246.
  • Sulaiman S, Ahmad S, Naz SS, et al. (2022). Synthesis of zinc oxide based etoricoxib and montelukast nanoformulations and their evaluation through analgesic, anti-inflammatory, anti-pyretic and acute toxicity activities. J King Saud Univ Sci 34:101938.
  • Suzuki M, Takebe G, Takagi T, et al. (2022). Characterization of novel paclitaxel nanoparticles prepared by laser irradiation. Chem Pharm Bull (Tokyo) 70:269–276.
  • Tan WK, Asami K, Maegawa K, et al. (2020). Fe3O4-embedded rGO composites as anode for rechargeable FeOx-air batteries. Mater Today Commun 25:101540.
  • Vemuri SK, Halder S, Banala RR, et al. (2022). Modulatory effects of biosynthesized gold nanoparticles conjugated with curcumin and paclitaxel on tumorigenesis and metastatic pathways-in vitro and in vivo studies. IJMS 23:2150.
  • Vergote I, Bergfeldt K, Franquet A, et al. (2020). A randomized phase III trial in patients with recurrent platinum sensitive ovarian cancer comparing efficacy and safety of paclitaxel micellar and Cremophor EL-paclitaxel. Gynecol Oncol 156:293–300.
  • Vieira J, Maurmann N, Venturini J, et al. (2022). PCL-coated magnetic Fe3O4 nanoparticles: production, characterization and viability on stem cells. Mater. Today Commun 31:103416.
  • Wala K, Szlasa W, Sauer N, et al. (2022). Anticancer efficacy of 6-gingerol with paclitaxel against wild type of human breast adenocarcinoma. Molecules 27:2693.
  • Wang HY, Cheng Y, Mao C, et al. (2021a). Emerging mechanisms and targeted therapy of ferroptosis in cancer. Mol Ther 29:2185–2208.
  • Wang K, Shen RY, Meng TT, et al. (2022a). Nano-drug delivery systems based on different targeting mechanisms in the targeted therapy of colorectal cancer. Molecules 27:2981.
  • Wang XP, Wang GM, Li JB, et al. (2022b). A simple and straightforward polymer post-modification method for wearable difluoroboron beta-diketonate luminescent sensors. Polymer 239:124449.
  • Wang YK, Chiang WC, Kuo FC, et al. (2018). Levels of malondialdehyde in the gastric juice: its association with Helicobacter pylori infection and stomach diseases. Helicobacter 23:e12460.
  • Wang YQ, Kanneganti T. (2021b). From pyroptosis, apoptosis and necroptosis to PANoptosis: a mechanistic compendium of programmed cell death pathways. Comput Struct Biotechnol J 19:4641–4657.
  • Webster EM, Dugan KB, Mcnamara B, et al. (2020). Surgical approach for interval debulking after neoadjuvant chemotherapy for treatment of advanced ovarian cancer: a single-institution retrospective cohort study. Gynecol Oncol 159:131.
  • Wei M, Wang XC, Zimmerman DN, et al. (2021b). Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer. Breast Cancer Res Treat 187:287–294.
  • Wu WN, Roy P. (2022). Sialic acid binding sites in VP2 of bluetongue virus and their use during virus entry. J Virol 96:e01677.
  • Xie YX, Gou QH, Zhang YJ, et al. (2022a). Association between age at initial diagnosis and post-metastasis mortality among women with recurrent metastatic breast cancer in China. BMC Cancer 22:385.
  • Xie Z, Lu G, Zhou R, Ma Y. (2022b). Thiacloprid-induced hepatotoxicity in zebrafish: activation of the extrinsic and intrinsic apoptosis pathways regulated by p53 signaling pathway. Aquat Toxicol 246:106147.
  • Yin XL, Zhang TC, Zhang Y. (2022). The global, regional, and national disease burden of breast cancer attributable to low physical activity from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019. Int J Behav Nutr Phy 19:42.
  • Yoko A, Kamonvarapitak T, Seong G, et al. (2022). Supercritical hydrothermal synthesis of organic-modified Ce1-xZrxO2-δ (0 ≤ x ≤ 1) nanoparticles as a low-temperature oxygen carrier. Chemnanomat 8:e202100495.
  • Yu DL, Lou ZP, Ma FY, Najafi M. (2022a). The interactions of paclitaxel with tumour microenvironment. Int Immunopharmacol 105:108555.
  • Yu LL, Liu M, Zhang YL, et al. (2022b). Magnetically induced self-assembly DNAzyme electrochemical biosensor based on gold-modified α-Fe2O3/Fe3O4 heterogeneous nanoparticles for sensitive detection of Ni2. +. Nanotechnology 33:095601.
  • Yuan C, Wang D, Zhang N, et al. (2020). DNA damage/cGAS-triggered up-regulation of MALAT1 promotes undesirable inflammatory responses in radiotherapy of cancer. Biochem Biophys Res Commun 528:746–752.
  • Zhang HP, Chen SY, Shan YH, et al. (2022). Highly effective lead ion adsorption by manganese-dioxide-supported core-shell structured magnetite. Front Env Sci 10:925205.
  • Zhang W, Chen Y, Wang B, et al. (2022a). Facile preparation of paclitaxel nano-suspensions to treat lung cancer. j Biomater Tissue Eng 12:690–694.
  • Zhang YL, Liu M, Pan S, et al. (2022b). A magnetically induced self-assembled and label-free electrochemical aptasensor based on magnetic Fe3O4/Fe2O3@Au nanoparticles for VEGF165 protein detection. Appl Surf Sci 580:152362.
  • Zhao YL, Ma GZ, Wang SP. (2022). Magnetic nanoparticle tracking for one-step protein separation and binding kinetics analysis. J Electrochem Soc 169:057509.
  • Zheng YH, Huang Y, Shi HB, Fu L. (2019). Green biosynthesis of ZnO nanoparticles by plectranthus amboinicus leaf extract and their application for electrochemical determination of norfloxacin. Inorg Nano-Met Chem 49:277–282.
  • Zhu LJ, Chen DZ, Zhu Y, et al. (2021). GPX4-regulated ferroptosis mediates S100-induced experimental autoimmune hepatitis associated with the Nrf2/HO-1 signaling pathway. Oxid Med Cell Longev 2021:6551069.